Shared Content Block:
Styles -- modify testimonial colors
The mission of the RNA Bioscience Initiative (RBI) is to cultivate a vibrant center of discovery and innovation in RNA biology, informatics, diagnostics, and therapy. Our goal is to provide a fluid pipeline from basic to clinical RNA research at the Anschutz Medical Campus.
December 17, 2020
It took decades of basic research on RNA to lay the foundation for two groundbreaking vaccines that will touch the lives of hundreds of millions of people this year. Both the Pfizer and Moderna vaccines use messenger RNA, or mRNA, to encode information that helps the body recognize and fight the novel coronavirus.
October 7, 2020
Jennifer Doudna, who studied RNA at the University of Colorado's Boulder campus in the 1990s, was co-recipient of the 2020 Nobel Prize in Chemistry for her work on the gene-editing technology CRISPR-Cas9.
January 1, 2021
Congratulations to Roberto Castro-Gutierrez, Raeann Goering, Divya Kolakada, Nicole Moss, and Matthew Szucs the RBI 2020-2021 RNA Scholars. These five graduate students were selected from a pool of 9 accomplished applicants. Each displays outstanding promise toward advancing RNA biology.
October 6, 2020
The RBI co-director was one of nine winners selected to pursue a high-risk high-reward project. Dr. Hesselberth will work to develop new approaches to measure biochemical heterogeneity at single-cell resolution
August 17, 2020
This RBI faculty member, one of three highly accomplished awardees, was recognized for her groundbreaking work on RNA surveillance and how dysregulation of this process contributes to disease.
The RBI has made CU Anschutz a clear hub of RNA biology expertise, raising the status of the university and its researchers in the eyes of scientists at institutions around the country and the world. The RBI sets CU Anschutz up as a leader in the exciting and groundbreaking field of RNA biology.